title: Quantitative evaluation of muscle weakness in scleroderma patients using magnetic resonance imaging and spectroscopy.
authors.forename: L E
authors.initials: LE
authors.lastname: King
authors.forename: N J
authors.initials: NJ
authors.lastname: Olsen
authors.forename: D
authors.initials: D
authors.lastname: Puett
authors.forename: T L
authors.initials: TL
authors.lastname: Vital
authors.forename: M
authors.initials: M
authors.lastname: Schulman
authors.forename: J H
authors.initials: JH
authors.lastname: Park
mesh_terms: D000273:Adipose Tissue / Q000473:pathology; D006801:Humans; D008279:Magnetic Resonance Imaging; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008875:Middle Aged; D009119:Muscle Contraction / Q000502:physiology*; D009132:Muscles / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D010725:Phosphocreatine / Q000378:metabolism; D010758:Phosphorus / Q000378:metabolism; D012595:Scleroderma, Systemic / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*
chemical_list: D010725:Phosphocreatine; D010758:Phosphorus